Mountain High Appoints Leading Cannabis Authority Dr. Robert Melamede Ph.D. as Scientific Advisor

Mountain High Appoints Leading Cannabis Authority Dr. Robert Melamede Ph.D. as 
Scientific Advisor 
DENVER, CO -- (Marketwired) -- 04/16/14 --  Mountain High
Acquisitions Corp. (OTCQB: MYHI) ("Mountain High" or the "Company"),
is pleased to announce that leading cannabis authority Dr. Robert
Melamede, Ph.D. has joined the Advisory Board of the Company. 
"Dr. Melamede is a visionary and a pioneer in the field of medicinal
cannabis research, so we are greatly honored that he has agreed to
join our team as Scientific Advisor," stated Mr. Alan Smith,
President of Mountain High Acquisitions Corp. "His years of leading
scientific research and cannabis advocacy have earned him a
reputation as a vital industry source of knowledge, opinion, industry
contacts, and inspiration. As our new Scientific Advisor, we are
confident that he will be instrumental in helping us achieve our
corporate objectives. In particular, his advice will be invaluable as
we provide additional complementary services to current and future
cannabis growing tenants and strategically develop our properties for
use by the cannabis industry."  
Dr. Robert Melamede is recognized as a leading authority on the
therapeutic uses of cannabis, and has authored or co-authored dozens
of papers on a wide variety of scientific subjects. Dr. Melamede is
the President of Cannabis Science, Inc. (OTCQB: CBIS), a medical
cannabis research and development company, and an advisor to
Enertopia Corporation (OTCQB: ENRT), a company with a medical
marijuana cultivation joint venture. Dr. Melamede also serves on the
Editorial Board of The Journal of the International Association for
Cannabis as Medicine, the Scientific Advisory Board of Americans for
Safe Access, Sensible Colorado, Scientific Advisor for Cannabis
Therapeutics, as well as a variety other of state dispensaries and
marijuana patient advocacy groups. Dr. Melamede has a Ph.D. in
Molecular Biology and Biochemistry from the City University of New
York. Dr. Melamede retired as Chairman of the Biology Department at
University of Colorado, Colorado Springs, in 2005, where he continues
to teach and research cannabinoids, cancer, and DNA repair.  
About Mountain High Acquisitions Corp. (MYHI) 
Mountain High Acquisitions Corp. is a strategic real estate holding
company whose primary focus is the acquisition and development of
commercial properties to be leased and utilized by the marijuana
industry. Mountain High's current portfolio includes three Colorado
properties zoned for commercial marijuana cultivation: Isabelle,
Madison, and Pueblo.  
Disclaimer/Safe Harbor: This Mountain High Acquisitions Corp. news
release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include failure to
meet schedule or performance requirements of the Company's contracts,
the Company's liquidity position, the Company's ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur as planned or at all. The Company does not
and will not grow, harvest, distribute, or sell cannabis or any
substances that violate United States law or the Controlled
Substances Act, nor does it intend to do so in the future.  
Investor/Media Contact: 
Mountain High Acquisitions Corp. 
Investor Relations
(844) 686-0420 (Toll-free)
E-mail: investors@moutainhighac.com 
Website: www.mountainhighac.com 
 
 
Press spacebar to pause and continue. Press esc to stop.